40 Compared with MCAVI, treatment with carboplatin plus gemcitabine resulted in a higher OR (41 versus 30%, respectively) that did not reach statistical significance.
← all excerpts
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter.
1
—
—